[1]
V. Feldrihan, A. Benea, and M. L. Junie, “Long-term Antiviral Hepatitis C treatment associated with Rods and Ring Cytoplasmic antibodies”, Med Pharm Rep, vol. 92, no. 1, pp. 87–90, Jan. 2019.